论文部分内容阅读
重症肌无力(myastheniagravis,MG)是由乙酰胆碱受体抗体(acetylcholinereceptorantibody,AchRab)介导、细胞免疫依赖及补体参与的神经肌肉接头处传递障碍的自身免疫性疾病。自从认识到AchRab在MG致病机制中起关键作用后,以直接清除MG患者血中的致病抗体为目的的血液净化治疗受
Myasthenia gravis (MG) is an autoimmune disease mediated by acetylcholine receptor monoenergetic antibody (AchRab), a cell-mediated immune-dependent and complement-involved neuromuscular junction. Since the recognition that AchRab plays a pivotal role in the pathogenesis of MG, the blood purification treatment for the purpose of directly eliminating pathogenic antibodies in the blood of patients with MG